Clinical trial

Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects

NCT01289080

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-01-01

PhasePHASE1

Study timeline

Study start (unknown)2011-01-01Date precision: month

Registry last updated2015-10-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Psychiatric Disordersunresolved

Interventions

OPC-34712DRUG

Sponsors & collaborators

Otsuka Pharmaceutical Development & Commercialization, Inc.lead sponsor

Mapped research locations

MiamiFlorida, United States1 MinneapolisMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01289080 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.